| 000 | 01461 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250514073402.0 | ||
| 264 | 0 | _c20040329 | |
| 008 | 200403s 0 0 eng d | ||
| 022 | _a1567-5769 | ||
| 024 | 7 |
_a10.1016/S1567-5769(03)00012-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRasi, G | |
| 245 | 0 | 0 |
_aCombination therapy in the treatment of chronic viral hepatitis and prevention of hepatocellular carcinoma. _h[electronic resource] |
| 260 |
_bInternational immunopharmacology _cAug 2003 |
||
| 300 |
_a1169-76 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAdjuvants, Immunologic _xtherapeutic use |
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xprevention & control |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aHepatitis B, Chronic _xcomplications |
| 650 | 0 | 4 |
_aHepatitis C, Chronic _xcomplications |
| 650 | 0 | 4 |
_aHepatitis, Viral, Human _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver Neoplasms _xprevention & control |
| 650 | 0 | 4 | _aThymalfasin |
| 650 | 0 | 4 |
_aThymosin _xanalogs & derivatives |
| 700 | 1 | _aPierimarchi, P | |
| 700 | 1 | _aSinibaldi Vallebona, P | |
| 700 | 1 | _aColella, F | |
| 700 | 1 | _aGaraci, E | |
| 773 | 0 |
_tInternational immunopharmacology _gvol. 3 _gno. 8 _gp. 1169-76 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S1567-5769(03)00012-2 _zAvailable from publisher's website |
| 999 |
_c12640395 _d12640395 |
||